Pharma cos can supply generic Bedaquiline to other countries

Multinational pharmaceutical company Johnson & Johnson (J&J) has announced that it will not enforce secondary patents for its anti-TB drug Bedaquiline in low and middle income countries. This means that Indian pharmaceutical companies will be able to supply generic versions of the drug without the fear of litigation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hOSn4cb
via IFTTT